Cargando…
Clinical Trials of Potential Cognitive-Enhancing Drugs in Schizophrenia: What Have We Learned So Far?
In light of the number of studies conducted to examine the treatment of cognitive impairment associated with schizophrenia (CIAS), we critically reviewed recent CIAS trials. Trials were identified through searches of the website “www.clinicaltrials.gov” using the terms “schizophrenia AND cognition,”...
Autores principales: | Keefe, Richard S. E., Buchanan, Robert W., Marder, Stephen R., Schooler, Nina R., Dugar, Ashish, Zivkov, Milana, Stewart, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576170/ https://www.ncbi.nlm.nih.gov/pubmed/22114098 http://dx.doi.org/10.1093/schbul/sbr153 |
Ejemplares similares
-
Theory: Historical perspective and what have we learned from the Higgs so far
por: Ellis, Jonathan R.
Publicado: (2022) -
COVID-19: What We Have Learned So Far
por: Clifford, Theresa
Publicado: (2020) -
Pediatric Myocarditis: What Have We Learnt So Far?
por: Pomiato, Elettra, et al.
Publicado: (2022) -
Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014) -
The hypocretins and the reward function: what have we learned so far?
por: Boutrel, Benjamin, et al.
Publicado: (2013)